Pharmacologic Management of BPD: Recent Developments-Interview

Pharmacologic Management of BPD: Recent Developments-Interview

In this interview, Dr. Paul Links reviews essential principles in the management of borderline personality disorder. He presents therapeutic options, such as psychotherapy, antipsychotics, mood stabilizers, anti-adrenergic agents, and omega-3 fatty acids, for the management of borderline personality disorder and its associated symptoms.

  • Provider:Medical Academy, LLC
  • Activity Link: https://psychopharmacologyinstitute.com/publication/pharmacologic-management-of-bpd-recent-developments-interview-2694?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
  • Start Date: 2023-01-01 06:00:00
  • End Date: 2023-01-01 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Performance
  • Provider Ship: Jointly Provided
  • Registration: Limited
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.